Literature DB >> 53841

Multiple active sites on human interferons.

K Paucker, B J Dalton, C A Ogburn, E Törmä.   

Abstract

Human interferons stimulated in peripheral leukocytes and foreskin fibroblasts are active in cultures of human and rabbit cells. The dominant factors in leukocyte and fibroblast interferons responsible for antiviral activity in rabbit cells were shown to be antigenically distinct from each other as well as from rabbit interferon. In addition, leukocyte interferon contained also a minor component with antigenic determinants characteristic of fibroblast specificity, which could be isolated by affinity chromatography on Sepharose-bound antibodies directed against firboblast interferon. Neutralization tests with selected anti-interferon sera suggested that the antiviral activities of leukocyte and fibroblast interferons in human and rabbit cells were associated with single molecules. A model is proposed where molecules of human interferon contain multiple reactive sites each of which is capable of interaction with cells of a different species. The number and distribution of these determinant sites may vary with the source of the human interferon and account for the differential in antiviral protection expressed in homologous and phylogenetically unrelated host cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53841      PMCID: PMC388768          DOI: 10.1073/pnas.72.11.4587

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies.

Authors:  K Berg; C A Ogburn; K Paucker; K E Mogensen; K Cantell
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

2.  Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity.

Authors:  W E Stewart; J Desmyter
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

3.  Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons.

Authors:  W E Stewart II; P De Somer; V G Edy; K Paucker; K Berg; C A Ogburn
Journal:  J Gen Virol       Date:  1975-03       Impact factor: 3.891

4.  Immunology of interferons. II. Heterospecific activities of human interferons and their neutralization by antibody.

Authors:  R E Levy-Koenig; R R Golgher; K Paucker
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

5.  Immunology of interferons. I. Immune response to protective and nonprotective interferons.

Authors:  R E Levy-Koenig; M J Mundy; K Paucker
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

6.  Production of interferon by human leukocytes in vitro.

Authors:  H Strander; K Cantell
Journal:  Ann Med Exp Biol Fenn       Date:  1966

7.  [Biologic activity of human interferon on the simian species in vitro and in vivo].

Authors:  R Falcoff; E Falcoff; P Dubouche; C Chany
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1968-01-15

8.  Some biological characters of cell lines derived from normal rabbit kidney.

Authors:  G J Christofinis; A J Beale
Journal:  J Pathol Bacteriol       Date:  1968-04

9.  A human interferon that crosses the species line.

Authors:  J Desmyter; W E Rawls; J L Melnick
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

10.  Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons.

Authors:  M J Valle; G W Jordan; S Haahr; T C Merigan
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

View more
  13 in total

Review 1.  Antiviral activity of interferons.

Authors:  R M Friedman
Journal:  Bacteriol Rev       Date:  1977-09

Review 2.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

3.  Enhancement of cellular protein synthesis sensitivity to diphtheria toxin by interferon.

Authors:  M Aboud; T Michalski-Stern; Y Nitzan; S Salzberg
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

4.  Antigenic properties of human lymphoblastoid interferons.

Authors:  B J Dalton; K Paucker
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

5.  Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity.

Authors:  L D Kohn; R M Friedman; J M Holmes; G Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

6.  Affinity chromatography of primary human amnion interferon.

Authors:  P C Ferreira; M Paucker; R R Golgher; K Paucker
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

7.  Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens.

Authors:  S E Starr; B Dalton; T Garrabrant; K Paucker; S A Plotkin
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

8.  Biological properties of human interferon fractions obtained by blue sepharose chromatography.

Authors:  J S Erickson; B J Dalton; K Paucker
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Adsorption of interferon to homologous and heterologous cells. Brief report.

Authors:  M Degré
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Restoration of normal febrile response to endotoxin in pyrogen-tolerant rabbits by injection with human beta interferon.

Authors:  H Kawasaki; M Moriyama; Y Ohtani; M Naitoh; H Nariuchi; A Tanaka
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.